Healthtech Startups
17,201 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
HearHero works to raise awareness of Sudden Cardiac Arrest and expand access to defibrillation, in partnership with cardiovascular care organizations. It operates in the cardiac health and emergency medical device space.
0 investors
Hedge Health provides a patient engagement and home exercise program platform for physical therapists and rehabilitation clinics to improve patient adherence and outcomes between in-office sessions. The app enables practitioners to create custom exercise programs, track patient progress, and reduce administrative burden.
0 investors
Heka Health builds mobile health solutions that use health sensors and mobile technology to connect individuals and their data with people and resources supporting their wellbeing, combining data analytics with human intervention to deliver personalized health insights. The company partners with organizations across the healthcare ecosystem to develop programs aimed at improving clinical outcomes and lowering cost of care.
0 investors
0 investors
Helix BioMedix is a publicly traded company (OTCMKTS: HXBM). The stock information page provides investor relations and transfer agent details but does not describe the company's products or business activities.
0 investors
0 investors
Helocyte is a biotechnology company developing cell-based therapies and life sciences programs. The company focuses on advancing breakthrough treatments within the biotech and life sciences sector.
0 investors
Hemanext develops oxygen-controlled storage technology to preserve red blood cell quality and function during transfusion storage. The company serves hospitals and blood establishments seeking to improve patient outcomes in transfusion medicine.
0 investors
0 investors
0 investors
Hepanova is a clinical-stage biotech developing first-in-class oral small-molecule therapeutics for chronic liver diseases and inflammatory conditions, including MASH, liver fibrosis, and IBD. Its lead candidate, HPN-01, is an oral dual IKKΞ±/IKKΞ² inhibitor that has completed a U.S. Phase 1 trial.
0 investors
Hepion Pharma is a pharmaceutical company with a therapeutic focus on hepatocellular carcinoma (liver cancer). This page is an investor presentations section with no substantive content available.
0 investors
0 investors